Novel germline mutation (300‐305delAGTTGA) in the human MSH2 gene in hereditary non‐polyposis colorectal cancer (HNPCC)

S. Glasl,L. Papatheodorou,G. Baretton,C. Jung,M. Gross
DOI: https://doi.org/10.1002/1098-1004(200007)16:1<91::AID-HUMU22>3.0.CO;2-A
2000-07-01
Human Mutation
Abstract:Hereditary non‐polyposis colorectal cancer (HNPCC) is a common hereditary syndrome characterized by the high incidence and early onset of colorectal cancer. The majority of the HNPCC families carry germline mutations in either the MSH2 or the MLH1 mismatch repair gene. A 46 year‐old female patient whose family history fulfilled the Amsterdam criteria for HNPCC was diagnosed with undifferentiated adenocarcinoma of the transverse colon. Recognizing the Lynch 2 syndrome (the existance of multiple HNPCC related cancers in a pedigree), we used polymerase chain reaction followed by direct sequencing to screen the coding regions of both the MSH2 and the MLH1 genes for germline mutations in DNA from the patient . We detected a novel germline mutation (300‐305delAGTTGA) in exon 2 of human MSH2. We noted microsatellite instability in four microsatellite loci. Immunohistochemistry showed a lack of expression of the MSH2 gene product in the tumor, suggesting that the mutation is a disease‐causing mutation. Hum Mutat 16:91–92, 2000. © Wiley‐Liss, Inc.
What problem does this paper attempt to address?